These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 17543151)

  • 21. Decrease in anti-Proteus mirabilis but not anti-Escherichia coli antibody levels in rheumatoid arthritis patients treated with fasting and a one year vegetarian diet.
    Kjeldsen-Kragh J; Rashid T; Dybwad A; Sioud M; Haugen M; Førre O; Ebringer A
    Ann Rheum Dis; 1995 Mar; 54(3):221-4. PubMed ID: 7748020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The specificity of the anti-Proteus antibody response in tissue-typed rheumatoid arthritis (RA) patients from Brest.
    Fielder M; Tiwana H; Youinou P; Le Goff P; Deonarain R; Wilson C; Ebringer A
    Rheumatol Int; 1995; 15(2):79-82. PubMed ID: 7481485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The link between Proteus mirabilis, environmental factors and autoantibodies in rheumatoid arthritis.
    Rashid T; Ebringer A; Wilson C
    Clin Exp Rheumatol; 2017; 35(5):865-871. PubMed ID: 28516867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-cyclic citrullinated peptide antibody isotypes in rheumatoid arthritis: association with disease duration, rheumatoid factor production and the presence of shared epitope.
    Lakos G; Soós L; Fekete A; Szabó Z; Zeher M; Horváth IF; Dankó K; Kapitány A; Gyetvai A; Szegedi G; Szekanecz Z
    Clin Exp Rheumatol; 2008; 26(2):253-60. PubMed ID: 18565246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibacterial and antipeptide antibodies in Japanese and Finnish patients with rheumatoid arthritis.
    Rashid T; Leirisalo-Repo M; Tani Y; Hukuda S; Kobayashi S; Wilson C; Bansal S; Ebringer A
    Clin Rheumatol; 2004 Apr; 23(2):134-41. PubMed ID: 15045628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytotoxicity responses to peptide antigens in rheumatoid arthritis and ankylosing spondylitis.
    Wilson C; Rashid T; Tiwana H; Beyan H; Hughes L; Bansal S; Ebringer A; Binder A
    J Rheumatol; 2003 May; 30(5):972-8. PubMed ID: 12734891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rheumatoid Arthritis Patients With Circulating Extracellular Vesicles Positive for IgM Rheumatoid Factor Have Higher Disease Activity.
    Arntz OJ; Pieters BCH; Thurlings RM; Wenink MH; van Lent PLEM; Koenders MI; van den Hoogen FHJ; van der Kraan PM; van de Loo FAJ
    Front Immunol; 2018; 9():2388. PubMed ID: 30420853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypogalactosylation of immunoglobulin G in rheumatoid arthritis: relationship to HLA-DRB1 shared epitope, anticitrullinated protein antibodies, rheumatoid factor, and correlation with inflammatory activity.
    Schwedler C; Häupl T; Kalus U; Blanchard V; Burmester GR; Poddubnyy D; Hoppe B
    Arthritis Res Ther; 2018 Mar; 20(1):44. PubMed ID: 29540200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The presence of anti-LPS antibodies and human serum activity against Proteus mirabilis S/R forms in correlation with TLR4 (Thr399Ile) gene polymorphism in rheumatoid arthritis.
    Arabski M; Fudala R; Koza A; Wasik S; Futoma-Koloch B; Bugla-Ploskonska G; Kaca W
    Clin Biochem; 2012 Nov; 45(16-17):1374-82. PubMed ID: 22749779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between anti-Proteus antibodies and isolation rates of P. mirabilis in rheumatoid arthritis.
    Wilson C; Thakore A; Isenberg D; Ebringer A
    Rheumatol Int; 1997; 16(5):187-9. PubMed ID: 9032817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rheumatoid Factor, Anti-Cyclic Citrullinated Peptide Antibody, C-Reactive Protein, and Erythrocyte Sedimentation Rate for the Clinical Diagnosis of Rheumatoid Arthritis.
    Shen R; Ren X; Jing R; Shen X; Chen J; Ju S; Yang C
    Lab Med; 2015; 46(3):226-9. PubMed ID: 26199263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
    Greiner A; Plischke H; Kellner H; Gruber R
    Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Periodontal treatment decreases levels of antibodies to Porphyromonas gingivalis and citrulline in patients with rheumatoid arthritis and periodontitis.
    Okada M; Kobayashi T; Ito S; Yokoyama T; Abe A; Murasawa A; Yoshie H
    J Periodontol; 2013 Dec; 84(12):e74-84. PubMed ID: 23701010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-cyclic citrullinated peptide antibody and rheumatoid factor isotypes in Iranian patients with rheumatoid arthritis: evaluation of clinical value and association with disease activity.
    Shakiba Y; Koopah S; Jamshidi AR; Amirzargar AA; Massoud A; Kiani A; Nicknam MH; Nazari B; Nikbin B
    Iran J Allergy Asthma Immunol; 2014 Jun; 13(3):147-56. PubMed ID: 24659118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential response of the rheumatoid factor and anticitrullinated protein antibodies during adalimumab treatment in patients with rheumatoid arthritis.
    Bos WH; Bartelds GM; Wolbink GJ; de Koning MH; van de Stadt RJ; van Schaardenburg D; Dijkmans BA; Nurmohamed MT
    J Rheumatol; 2008 Oct; 35(10):1972-7. PubMed ID: 18785316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
    Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
    Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histological features of rheumatoid arthritis patients having antibodies to enterobacterial common antigens: correlation of antibody levels with semiquantitative histologic scores and laboratory markers.
    Aoki S; Mitsui T
    Clin Exp Rheumatol; 2005; 23(1):13-8. PubMed ID: 15789882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rheumatoid arthritis and Proteus: a possible aetiological association.
    Ebringer A; Khalafpour S; Wilson C
    Rheumatol Int; 1989; 9(3-5):223-8. PubMed ID: 2692130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis.
    De Rycke L; Verhelst X; Kruithof E; Van den Bosch F; Hoffman IE; Veys EM; De Keyser F
    Ann Rheum Dis; 2005 Feb; 64(2):299-302. PubMed ID: 15166003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measurement of biomarkers in juvenile idiopathic arthritis patients and their significant association with disease severity: a comparative study.
    Gilliam BE; Chauhan AK; Low JM; Moore TL
    Clin Exp Rheumatol; 2008; 26(3):492-7. PubMed ID: 18578976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.